2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/23657005/	Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study.	unassigned	-	
2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/22098444/	Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial.	unassigned	-	
2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/29026604/	Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study.	unassigned	-	
2.4.1.219	Diabetes Mellitus, Type 2	https://pubmed.ncbi.nlm.nih.gov/22098444/	Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial.	unassigned	-	
2.4.1.219	Diabetes Mellitus, Type 2	https://pubmed.ncbi.nlm.nih.gov/23657005/	Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study.	unassigned	-	
2.4.1.219	Diabetes Mellitus, Type 2	https://pubmed.ncbi.nlm.nih.gov/29026604/	Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study.	unassigned	-	
2.4.1.219	Gaucher Disease	https://pubmed.ncbi.nlm.nih.gov/33361282/	Human glucocerebrosidase mediates formation of xylosyl-cholesterol by ?-xylosidase and transxylosidase reactions.	unassigned	-	
2.4.1.219	Hyperglycemia	https://pubmed.ncbi.nlm.nih.gov/20165914/	Supplementing transglucosidase with a high-fiber diet for prevention of postprandial hyperglycemia in streptozotocin-induced diabetic dogs.	unassigned	-	
2.4.1.219	Movement Disorders	https://pubmed.ncbi.nlm.nih.gov/29026604/	Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study.	unassigned	-	
2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/22098444/	Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial.	diagnostic usage	1